Management Tracks: Lilly, LogicBio

Eli Lilly and Co. (NYSE:LLY) said Lilly SVP and Lilly Oncology President Sue Mahony will retire at the end of August. The pharma is searching for candidates to succeed Mahony.

Gene editing company LogicBio Therapeutics Inc. (Cambridge, Mass.) appointed Dean Falb as CSO. He was chief technology officer at Synlogic Inc. (NASDAQ:SYBX)...